In vitro permeation and biological activity of punicalagin and zinc (II) across skin and mucous membranes prone to Herpes simplex virus infection

Coadministration of pomegranate rind extract (PRE) and zinc (II) ions has recently been reported as a potential new topical treatment for Herpes simplex virus (HSV) infections. In the current work we examined the in vitro topical delivery of punicalagin (major phytochemical of PRE) and zinc from hyd...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of pharmaceutical sciences 2017-01, Vol.96, p.99-106
Hauptverfasser: Houston, David M.J., Robins, Bethan, Bugert, Joachim J., Denyer, Stephen P., Heard, Charles M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 106
container_issue
container_start_page 99
container_title European journal of pharmaceutical sciences
container_volume 96
creator Houston, David M.J.
Robins, Bethan
Bugert, Joachim J.
Denyer, Stephen P.
Heard, Charles M.
description Coadministration of pomegranate rind extract (PRE) and zinc (II) ions has recently been reported as a potential new topical treatment for Herpes simplex virus (HSV) infections. In the current work we examined the in vitro topical delivery of punicalagin (major phytochemical of PRE) and zinc from hydrogels across epithelial membranes that can become infected with HSV. Porcine epidermal, buccal and vaginal mucous membranes were excised and mounted in Franz diffusion cells and dosed with a simple hydrogel containing PRE and zinc sulphate (ZnSO4). The permeation of punicalagin and zinc were determined by HPLC and ICPMS respectively; punicalagin was also determined in the basal layers by reverse tape stripping. Receptor phases from the epidermal membrane experiment were also used to challenge HSV-1 in Vero host cells, and ex vivo porcine skin was used to probe COX-2 modulation. Punicalagin and zinc permeated each of the three test membranes, with significantly greater amounts of both delivered across the epidermal membrane. The amounts of punicalagin permeating the buccal and vaginal membranes were similar, although the amount of zinc permeating the vaginal membrane was comparatively very large – it is known that zinc interacts with vaginal mucosa. The punicalagin recovered by reverse tape stripping of the epidermal, buccal and vaginal membranes gave 0.47±0.016, 0.45±0.052 and 0.51±0.048nMcm−2 respectively, and were statistically the same (p
doi_str_mv 10.1016/j.ejps.2016.08.013
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1835388438</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0928098716303025</els_id><sourcerecordid>1835388438</sourcerecordid><originalsourceid>FETCH-LOGICAL-c400t-43b9aa93172eb460231b7df0e0c915f71a51a3894d5f5e31a20a6dcecc11341d3</originalsourceid><addsrcrecordid>eNp9kctu1TAQhi1ERQ-FF2CBvCyLhJk4F0digyqgR6rEpqwtx5lUPiR2sJOq7VvwxjicU5asbI-_-efyM_YOIUfA-uMhp8Mc8yLdc5A5oHjBdiibNoOmgJdsB20hM2hlc85ex3gAgFo28IqdF02FNZZyx37vHb-3S_B8pjCRXqx3XLued9aP_s4aPXJtFpuYR-4HPq9ui-k7e8SerDP8cr__kKjgY-Tx5-lnWo1fI59o6oJ2FPkcvCO-eH5NYU7vaKd5pIdUPiTOuoHMVv0NOxv0GOnt6bxgP75-ub26zm6-f9tffb7JTAmwZKXoWq1bgU1BXVlDIbBr-gEITIvV0KCuUAvZln01VCRQF6Dr3pAxiKLEXlywy6Nu6uvXSnFRk42GxjE1mxpXKEUlpCyFTGhxRP-OGGhQc7CTDo8KQW1WqIParFCbFQqkSlakpPcn_bWbqP-X8rz7BHw6ApSmvLcUVDSWnKHehrQK1Xv7P_0_zdOczA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1835388438</pqid></control><display><type>article</type><title>In vitro permeation and biological activity of punicalagin and zinc (II) across skin and mucous membranes prone to Herpes simplex virus infection</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Houston, David M.J. ; Robins, Bethan ; Bugert, Joachim J. ; Denyer, Stephen P. ; Heard, Charles M.</creator><creatorcontrib>Houston, David M.J. ; Robins, Bethan ; Bugert, Joachim J. ; Denyer, Stephen P. ; Heard, Charles M.</creatorcontrib><description>Coadministration of pomegranate rind extract (PRE) and zinc (II) ions has recently been reported as a potential new topical treatment for Herpes simplex virus (HSV) infections. In the current work we examined the in vitro topical delivery of punicalagin (major phytochemical of PRE) and zinc from hydrogels across epithelial membranes that can become infected with HSV. Porcine epidermal, buccal and vaginal mucous membranes were excised and mounted in Franz diffusion cells and dosed with a simple hydrogel containing PRE and zinc sulphate (ZnSO4). The permeation of punicalagin and zinc were determined by HPLC and ICPMS respectively; punicalagin was also determined in the basal layers by reverse tape stripping. Receptor phases from the epidermal membrane experiment were also used to challenge HSV-1 in Vero host cells, and ex vivo porcine skin was used to probe COX-2 modulation. Punicalagin and zinc permeated each of the three test membranes, with significantly greater amounts of both delivered across the epidermal membrane. The amounts of punicalagin permeating the buccal and vaginal membranes were similar, although the amount of zinc permeating the vaginal membrane was comparatively very large – it is known that zinc interacts with vaginal mucosa. The punicalagin recovered by reverse tape stripping of the epidermal, buccal and vaginal membranes gave 0.47±0.016, 0.45±0.052 and 0.51±0.048nMcm−2 respectively, and were statistically the same (p&lt;0.05). A 2.5 log reduction was achieved against HSV-1 using diffusion cell receptor phase, and COX-2 expression was reduced by 64% in ex vivo skin after 6h. Overall, a hydrogel containing 1.25mgmL−1 PRE and 0.25M ZnSO4 was able to topically deliver both the major bioactive compound within PRE and Zn (II) across all membranes and into the site specific region of Herpes simplex vesicular clusters, while maintaining potentiated virucidal and anti-inflammatory properties. This novel therapeutic system therefore has potential for the topical treatment of HSV infections. [Display omitted]</description><identifier>ISSN: 0928-0987</identifier><identifier>EISSN: 1879-0720</identifier><identifier>DOI: 10.1016/j.ejps.2016.08.013</identifier><identifier>PMID: 27516148</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject><![CDATA[Animals ; Anti-inflammatory ; Anti-Inflammatory Agents - administration & dosage ; Anti-Inflammatory Agents - pharmacology ; Antiviral Agents - administration & dosage ; Antiviral Agents - pharmacology ; Buccal cavity ; Cercopithecus aethiops ; Cyclooxygenase 2 - metabolism ; Drug delivery ; Female ; Herpes Simplex ; Herpes simplex virus ; Herpesvirus 1, Human - drug effects ; Herpesvirus 1, Human - growth & development ; Hydrogels - administration & dosage ; Hydrogels - pharmacology ; Hydrolyzable Tannins - administration & dosage ; Hydrolyzable Tannins - pharmacology ; Hypromellose Derivatives ; In Vitro Techniques ; Mucous Membrane - drug effects ; Mucous Membrane - metabolism ; Mucous Membrane - virology ; Pomegranate rind extract ; Punica granatum L ; Punicalagin ; Reverse tape stripping ; Skin ; Skin - drug effects ; Skin - metabolism ; Skin - virology ; Swine ; Vagina ; Vero Cells ; Virucidal ; Zinc ; Zinc Sulfate - administration & dosage ; Zinc Sulfate - pharmacology]]></subject><ispartof>European journal of pharmaceutical sciences, 2017-01, Vol.96, p.99-106</ispartof><rights>2016 Elsevier B.V.</rights><rights>Copyright © 2016 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c400t-43b9aa93172eb460231b7df0e0c915f71a51a3894d5f5e31a20a6dcecc11341d3</citedby><cites>FETCH-LOGICAL-c400t-43b9aa93172eb460231b7df0e0c915f71a51a3894d5f5e31a20a6dcecc11341d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ejps.2016.08.013$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27516148$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Houston, David M.J.</creatorcontrib><creatorcontrib>Robins, Bethan</creatorcontrib><creatorcontrib>Bugert, Joachim J.</creatorcontrib><creatorcontrib>Denyer, Stephen P.</creatorcontrib><creatorcontrib>Heard, Charles M.</creatorcontrib><title>In vitro permeation and biological activity of punicalagin and zinc (II) across skin and mucous membranes prone to Herpes simplex virus infection</title><title>European journal of pharmaceutical sciences</title><addtitle>Eur J Pharm Sci</addtitle><description>Coadministration of pomegranate rind extract (PRE) and zinc (II) ions has recently been reported as a potential new topical treatment for Herpes simplex virus (HSV) infections. In the current work we examined the in vitro topical delivery of punicalagin (major phytochemical of PRE) and zinc from hydrogels across epithelial membranes that can become infected with HSV. Porcine epidermal, buccal and vaginal mucous membranes were excised and mounted in Franz diffusion cells and dosed with a simple hydrogel containing PRE and zinc sulphate (ZnSO4). The permeation of punicalagin and zinc were determined by HPLC and ICPMS respectively; punicalagin was also determined in the basal layers by reverse tape stripping. Receptor phases from the epidermal membrane experiment were also used to challenge HSV-1 in Vero host cells, and ex vivo porcine skin was used to probe COX-2 modulation. Punicalagin and zinc permeated each of the three test membranes, with significantly greater amounts of both delivered across the epidermal membrane. The amounts of punicalagin permeating the buccal and vaginal membranes were similar, although the amount of zinc permeating the vaginal membrane was comparatively very large – it is known that zinc interacts with vaginal mucosa. The punicalagin recovered by reverse tape stripping of the epidermal, buccal and vaginal membranes gave 0.47±0.016, 0.45±0.052 and 0.51±0.048nMcm−2 respectively, and were statistically the same (p&lt;0.05). A 2.5 log reduction was achieved against HSV-1 using diffusion cell receptor phase, and COX-2 expression was reduced by 64% in ex vivo skin after 6h. Overall, a hydrogel containing 1.25mgmL−1 PRE and 0.25M ZnSO4 was able to topically deliver both the major bioactive compound within PRE and Zn (II) across all membranes and into the site specific region of Herpes simplex vesicular clusters, while maintaining potentiated virucidal and anti-inflammatory properties. This novel therapeutic system therefore has potential for the topical treatment of HSV infections. [Display omitted]</description><subject>Animals</subject><subject>Anti-inflammatory</subject><subject>Anti-Inflammatory Agents - administration &amp; dosage</subject><subject>Anti-Inflammatory Agents - pharmacology</subject><subject>Antiviral Agents - administration &amp; dosage</subject><subject>Antiviral Agents - pharmacology</subject><subject>Buccal cavity</subject><subject>Cercopithecus aethiops</subject><subject>Cyclooxygenase 2 - metabolism</subject><subject>Drug delivery</subject><subject>Female</subject><subject>Herpes Simplex</subject><subject>Herpes simplex virus</subject><subject>Herpesvirus 1, Human - drug effects</subject><subject>Herpesvirus 1, Human - growth &amp; development</subject><subject>Hydrogels - administration &amp; dosage</subject><subject>Hydrogels - pharmacology</subject><subject>Hydrolyzable Tannins - administration &amp; dosage</subject><subject>Hydrolyzable Tannins - pharmacology</subject><subject>Hypromellose Derivatives</subject><subject>In Vitro Techniques</subject><subject>Mucous Membrane - drug effects</subject><subject>Mucous Membrane - metabolism</subject><subject>Mucous Membrane - virology</subject><subject>Pomegranate rind extract</subject><subject>Punica granatum L</subject><subject>Punicalagin</subject><subject>Reverse tape stripping</subject><subject>Skin</subject><subject>Skin - drug effects</subject><subject>Skin - metabolism</subject><subject>Skin - virology</subject><subject>Swine</subject><subject>Vagina</subject><subject>Vero Cells</subject><subject>Virucidal</subject><subject>Zinc</subject><subject>Zinc Sulfate - administration &amp; dosage</subject><subject>Zinc Sulfate - pharmacology</subject><issn>0928-0987</issn><issn>1879-0720</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kctu1TAQhi1ERQ-FF2CBvCyLhJk4F0digyqgR6rEpqwtx5lUPiR2sJOq7VvwxjicU5asbI-_-efyM_YOIUfA-uMhp8Mc8yLdc5A5oHjBdiibNoOmgJdsB20hM2hlc85ex3gAgFo28IqdF02FNZZyx37vHb-3S_B8pjCRXqx3XLued9aP_s4aPXJtFpuYR-4HPq9ui-k7e8SerDP8cr__kKjgY-Tx5-lnWo1fI59o6oJ2FPkcvCO-eH5NYU7vaKd5pIdUPiTOuoHMVv0NOxv0GOnt6bxgP75-ub26zm6-f9tffb7JTAmwZKXoWq1bgU1BXVlDIbBr-gEITIvV0KCuUAvZln01VCRQF6Dr3pAxiKLEXlywy6Nu6uvXSnFRk42GxjE1mxpXKEUlpCyFTGhxRP-OGGhQc7CTDo8KQW1WqIParFCbFQqkSlakpPcn_bWbqP-X8rz7BHw6ApSmvLcUVDSWnKHehrQK1Xv7P_0_zdOczA</recordid><startdate>20170101</startdate><enddate>20170101</enddate><creator>Houston, David M.J.</creator><creator>Robins, Bethan</creator><creator>Bugert, Joachim J.</creator><creator>Denyer, Stephen P.</creator><creator>Heard, Charles M.</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20170101</creationdate><title>In vitro permeation and biological activity of punicalagin and zinc (II) across skin and mucous membranes prone to Herpes simplex virus infection</title><author>Houston, David M.J. ; Robins, Bethan ; Bugert, Joachim J. ; Denyer, Stephen P. ; Heard, Charles M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c400t-43b9aa93172eb460231b7df0e0c915f71a51a3894d5f5e31a20a6dcecc11341d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Animals</topic><topic>Anti-inflammatory</topic><topic>Anti-Inflammatory Agents - administration &amp; dosage</topic><topic>Anti-Inflammatory Agents - pharmacology</topic><topic>Antiviral Agents - administration &amp; dosage</topic><topic>Antiviral Agents - pharmacology</topic><topic>Buccal cavity</topic><topic>Cercopithecus aethiops</topic><topic>Cyclooxygenase 2 - metabolism</topic><topic>Drug delivery</topic><topic>Female</topic><topic>Herpes Simplex</topic><topic>Herpes simplex virus</topic><topic>Herpesvirus 1, Human - drug effects</topic><topic>Herpesvirus 1, Human - growth &amp; development</topic><topic>Hydrogels - administration &amp; dosage</topic><topic>Hydrogels - pharmacology</topic><topic>Hydrolyzable Tannins - administration &amp; dosage</topic><topic>Hydrolyzable Tannins - pharmacology</topic><topic>Hypromellose Derivatives</topic><topic>In Vitro Techniques</topic><topic>Mucous Membrane - drug effects</topic><topic>Mucous Membrane - metabolism</topic><topic>Mucous Membrane - virology</topic><topic>Pomegranate rind extract</topic><topic>Punica granatum L</topic><topic>Punicalagin</topic><topic>Reverse tape stripping</topic><topic>Skin</topic><topic>Skin - drug effects</topic><topic>Skin - metabolism</topic><topic>Skin - virology</topic><topic>Swine</topic><topic>Vagina</topic><topic>Vero Cells</topic><topic>Virucidal</topic><topic>Zinc</topic><topic>Zinc Sulfate - administration &amp; dosage</topic><topic>Zinc Sulfate - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Houston, David M.J.</creatorcontrib><creatorcontrib>Robins, Bethan</creatorcontrib><creatorcontrib>Bugert, Joachim J.</creatorcontrib><creatorcontrib>Denyer, Stephen P.</creatorcontrib><creatorcontrib>Heard, Charles M.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of pharmaceutical sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Houston, David M.J.</au><au>Robins, Bethan</au><au>Bugert, Joachim J.</au><au>Denyer, Stephen P.</au><au>Heard, Charles M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>In vitro permeation and biological activity of punicalagin and zinc (II) across skin and mucous membranes prone to Herpes simplex virus infection</atitle><jtitle>European journal of pharmaceutical sciences</jtitle><addtitle>Eur J Pharm Sci</addtitle><date>2017-01-01</date><risdate>2017</risdate><volume>96</volume><spage>99</spage><epage>106</epage><pages>99-106</pages><issn>0928-0987</issn><eissn>1879-0720</eissn><abstract>Coadministration of pomegranate rind extract (PRE) and zinc (II) ions has recently been reported as a potential new topical treatment for Herpes simplex virus (HSV) infections. In the current work we examined the in vitro topical delivery of punicalagin (major phytochemical of PRE) and zinc from hydrogels across epithelial membranes that can become infected with HSV. Porcine epidermal, buccal and vaginal mucous membranes were excised and mounted in Franz diffusion cells and dosed with a simple hydrogel containing PRE and zinc sulphate (ZnSO4). The permeation of punicalagin and zinc were determined by HPLC and ICPMS respectively; punicalagin was also determined in the basal layers by reverse tape stripping. Receptor phases from the epidermal membrane experiment were also used to challenge HSV-1 in Vero host cells, and ex vivo porcine skin was used to probe COX-2 modulation. Punicalagin and zinc permeated each of the three test membranes, with significantly greater amounts of both delivered across the epidermal membrane. The amounts of punicalagin permeating the buccal and vaginal membranes were similar, although the amount of zinc permeating the vaginal membrane was comparatively very large – it is known that zinc interacts with vaginal mucosa. The punicalagin recovered by reverse tape stripping of the epidermal, buccal and vaginal membranes gave 0.47±0.016, 0.45±0.052 and 0.51±0.048nMcm−2 respectively, and were statistically the same (p&lt;0.05). A 2.5 log reduction was achieved against HSV-1 using diffusion cell receptor phase, and COX-2 expression was reduced by 64% in ex vivo skin after 6h. Overall, a hydrogel containing 1.25mgmL−1 PRE and 0.25M ZnSO4 was able to topically deliver both the major bioactive compound within PRE and Zn (II) across all membranes and into the site specific region of Herpes simplex vesicular clusters, while maintaining potentiated virucidal and anti-inflammatory properties. This novel therapeutic system therefore has potential for the topical treatment of HSV infections. [Display omitted]</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>27516148</pmid><doi>10.1016/j.ejps.2016.08.013</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0928-0987
ispartof European journal of pharmaceutical sciences, 2017-01, Vol.96, p.99-106
issn 0928-0987
1879-0720
language eng
recordid cdi_proquest_miscellaneous_1835388438
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects Animals
Anti-inflammatory
Anti-Inflammatory Agents - administration & dosage
Anti-Inflammatory Agents - pharmacology
Antiviral Agents - administration & dosage
Antiviral Agents - pharmacology
Buccal cavity
Cercopithecus aethiops
Cyclooxygenase 2 - metabolism
Drug delivery
Female
Herpes Simplex
Herpes simplex virus
Herpesvirus 1, Human - drug effects
Herpesvirus 1, Human - growth & development
Hydrogels - administration & dosage
Hydrogels - pharmacology
Hydrolyzable Tannins - administration & dosage
Hydrolyzable Tannins - pharmacology
Hypromellose Derivatives
In Vitro Techniques
Mucous Membrane - drug effects
Mucous Membrane - metabolism
Mucous Membrane - virology
Pomegranate rind extract
Punica granatum L
Punicalagin
Reverse tape stripping
Skin
Skin - drug effects
Skin - metabolism
Skin - virology
Swine
Vagina
Vero Cells
Virucidal
Zinc
Zinc Sulfate - administration & dosage
Zinc Sulfate - pharmacology
title In vitro permeation and biological activity of punicalagin and zinc (II) across skin and mucous membranes prone to Herpes simplex virus infection
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-21T18%3A44%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=In%20vitro%20permeation%20and%20biological%20activity%20of%20punicalagin%20and%20zinc%20(II)%20across%20skin%20and%20mucous%20membranes%20prone%20to%20Herpes%20simplex%20virus%20infection&rft.jtitle=European%20journal%20of%20pharmaceutical%20sciences&rft.au=Houston,%20David%20M.J.&rft.date=2017-01-01&rft.volume=96&rft.spage=99&rft.epage=106&rft.pages=99-106&rft.issn=0928-0987&rft.eissn=1879-0720&rft_id=info:doi/10.1016/j.ejps.2016.08.013&rft_dat=%3Cproquest_cross%3E1835388438%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1835388438&rft_id=info:pmid/27516148&rft_els_id=S0928098716303025&rfr_iscdi=true